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Background: For titer assessment of human herpesvirus 6 (HHV-6), IFA targeting viral proteins or a TCID50 method
with ocular inspection for CPE can be used. These methods rely on the subjective decision of the assessor,
obstructing the ability to obtain unanimous results.
Findings: We have developed and validated an alternative TCID50 read-out approach where infection in the
titration culture plate is assessed by viral DNA load change by quantitative PCR. A ten time increase in viral DNA
load was determined as cut point for infection since that yielded a maximum correlation with viral protein
expression (93%). The average intra-assay CV was 9% for quantitative PCR read-out of TCID50 compared to 45% for
ocular inspection read-out of TCID50, 14% for IFA read-out of TCID50, and 43% for an infectious units approach
using IFA. The average inter-assay CV for quantitative PCR read-out of TCID50 was 73%, compared to 66%, 25% and
77% for the ocular inspection read-out for TCID50, IFA read-out of TCID50 and infectious unit approaches
respectively.
Conclusions: The quantitative PCR based read-out of TCID50 proved to be more robust and easier to interpret than
traditional TCID50 assessment approaches for HHV-6, and therefore it might be considered as an alternative method.
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It is crucial to have control of the viral titer in experi-
mental work with viruses. To facilitate comparisons be-
tween studies performed at different laboratories the use
of harmonized standard methods are desirable. For
human herpesvirus 6 (HHV-6) [1], a β-herpesvirus that
most people have been exposed to [2,3], the 50% tissue
culture infectivity dose (TCID50) method [4] is often
used for viral titer assessment. A commonly used read-
out is ocular inspection for cytopathic effects (CPE), i.e.
enlargement of the infected cells [5]. One obstacle with
this approach is that cells may enlarge even when not
infected. It is especially difficult at the borderline of in-
fection in titration series’ as cells enlarged due to infec-
tion tend to enlarge less with increased dilution of the
virus (Additional file 1: Figure S1). Immunofluorescence
assay (IFA) is an alternative read-out approach to ocular* Correspondence: Rasmus.Gustafsson@ki.se
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distribution, and reproduction in any mediuminspection in TCID50 assessment [6] or for calculation of
infectious units, i.e. the fraction of infected cells [7]. The
IFA based read-out is more distinct in discriminating
infected from uninfected cells but the staining is labori-
ous and a substantial number of cells need to be
counted to get reliable values. The monitoring of indi-
vidual cells implies a risk to misinterpret a cell’s positiv-
ity, a disadvantage of both ocular inspection and IFA
based read-outs. Hence, we developed and validated an
alternative read-out approach of TCID50 where the in-
crease in viral DNA load is measured in every titration
well of TCID50 culture plates using real-time quantita-
tive PCR (Q-PCR). This approach was compared with
ocular inspection and IFA read-outs of TCID50, and with
the infectious units approach described above.
HHV-6A (GS strain) [1] was propagated in the T-cell
line HSB-2 in GlutaMAX containing RPMI 1640
medium (Invitrogen, United Kingdom) supplemented
with 10% fetal bovine serum (HyClone, UT), 100 U/ml
penicillin and 100 μg/ml streptomycin (Invitrogen).
When approximately 50% of the live cells had enlarged,
the supernatant was harvested and frozen immediatelytral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Replication of HHV-6A (GS strain) followed by Q-PCR.
Data shown are mean results (± SEM) of triplicate cultures for every
multiplicity of infection (MOI). Connecting lines discontinue when
the viral DNA load dropped under the detection limit.
Figure 2 Determination of cut-point for infection. The optimal
cut-point for infection was found to be a ten times increase where
the correlation to protein expression was seen in 93% of the wells
by IFA with an antibody targeting the late viral protein gp116/54/64.
No well contained viral protein where the viral DNA load had not
increased ten times. Data shown are mean results (± SEM) from
three TCID50 plates.
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supernatant of passage 17 (P17) were inactivated by UV
light for 20 min or with heat treatment at 56°C for 1 h.
HHV-6A replication in HSB-2 cells was followed for ten
days using Q-PCR (Applied Biosystems, United Kingdom)
as previously described [8]. Prior to Q-PCR analysis, DNA
was extracted from the cell suspensions using a 96-well
plate bead-based kit according to the manufacturer’s proto-
col (MagMAX-96 Viral RNA Isolation Kit, Applied Biosys-
tems). To assess the HHV-6A DNA content in the viral
batches, Q-PCR was performed as described above after
DNA extraction using filter columns (QIAGEN GmbH,
Germany).
To set up the TCID50 culture plates, cell suspensions
of 40 μl 104 HSB-2 cells per well were seeded in round
bottom 96-well culture plates. The cells were inoculated
for 3–4 hours with 160 μl of five-fold dilutions of HHV-
6A supernatant, six replicates per dilution. Mock and
medium controls were included in triplicate wells on all
plates. The cells were washed once before 50–70 μl of
cell suspension were sampled from every well and stored
at −80°C as zero day post infection (dpi) samples. The
remaining cell suspensions were incubated for seven
days at 37°C. At seven dpi, the thawed zero dpi plate
and the seven dpi plates were subjected to DNA extrac-
tion using the bead-based kit described above. There-
after the viral DNA was quantified by Q-PCR as
described above.
For IFA the cells were fixed onto glass slides with a 1:1
mixture of acetone and methanol at −20°C for 10 min-
utes, blocked with 5% goat serum and 3% BSA in PBS,
and stained with a primary mouse monoclonal antibody
specific to the HHV-6 glycoprotein gp116/54/64
(Advanced Biotechnologies, MD). The staining was
visualized by an Alexa 633 conjugated goat anti-mouse
IgG (Invitrogen). Staining with 4',6-diamidino-2-pheny-
lindole (Vector laboratories, CA) was used to visualize
the cell nuclei. Cover slips were mounted with mounting
media (DAKO A/S, Denmark), and the slides were ana-
lyzed using a confocal microscope (Leica Microsystems,
Germany). The fraction of infected cells was determined
by manual counting. If ≥1/3 of the cells contained viral
protein, ≥25 cells per well were counted and if <1/3 of
the cells contained viral protein, ≥100 cells per well were
counted. Wells where ≥2% of the cells stained positive
were considered infected. The level of viral DNA load
increase in each well was correlated to the IFA staining
constructing a formula in the software Excel (Microsoft,
WA). This formula asks whether the viral DNA in a cer-
tain well in the TCID50 plate has shifted a certain num-
ber of times which is set, and if the very same well was
positive in IFA or not.
For comparisons with the Q-PCR read-out, all TCID50
plates were assessed by ocular inspection using a phasecontrast microscope by two independent inspectors
(ocular TCID50). Wells were considered as infected if at
least one enlarged cell was found. For both read-out
approaches the TCID50 was calculated according to the
Reed and Muench formula [4].
The TCID50 results determined by Q-PCR (Q-PCR
TCID50) was compared with the infectious units assess-
ment by IFA [7] (personal communication with Louis
Flamand) at three time points for P19 and one for P27.
Briefly, 2.5*105 HSB-2 cells were inoculated as described
above with various dilutions of virus in triplicate wells
for every dilution. At two dpi the cells were subjected to
IFA targeting the early viral protein p41 (clone 9A5D12,
Santa Cruz Biotech. Inc., CA) as described above. The
Table 1 Titer assessment for HHV-6A GS strain batches expressed as TCID50 determined by Q-PCR, ocular inspection or
immunofluorescence assay (IFA), and as infectious units (Inf U) determined by IFA
Batch Q-PCR Ocular inspection Inf U/ml IFA HHV-6A
(passage) TCID50/ml TCID50/ml TCID50/ml DNA cop/ml
P17 1215 ±566 (x3)1 771 ±466 (x3) nd2 972 ±719 (x2) 7.6e8 ±1.4e8 (x2)
P19 806 ±679 (x5) 465 ±408 (x5) 2.5e4 ±1.6e4 (x3) 649 N/A3 (x1) 16.0e8 ±1.3e8 (x2)
P21 6 ±8 (x2) 14 ±6 (x2) nd nd 7.7e8 ±0.15e8 (x2)
P27 7 ±6 (x3) 30 ±15 (x3) 3.9e4 N/A (x1) 13 ±3 (3x) nd
P17 UV-inact. 0 N/A (x1) 0 N/A (x1) nd nd nd
P17 heat-inact. 20 N/A (x1) 4 N/A (x1) nd nd nd
1 Number of replications of titer assessments for each passage.
2 nd: Not done.
3 N/A: Not applicable.
Ocular inspection was performed by two independent assessors. Data presented are means ± standard deviations.
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calculated by multiplying the fraction of infected cells
with the total number of cells at zero dpi and dilution
factors.
To determine the optimal time-point for viral DNA
load increase measurements, virus replication was fol-
lowed for ten days. Seven days was required to reach
sufficient increase in viral DNA (Figure 1) and was
therefore chosen as the harvest time-point. To set the
cut point of relative viral DNA increase corresponding
to positive infection, the viral DNA load increase was
correlated with viral protein expression. IFA was per-
formed at seven dpi on cells from every well in three
TCID50 plates for two different virus batches. The opti-
mal cut point was found to be a ten time increase in
viral DNA, where the correlation to protein expression
was seen in 93% of the wells (Figure 2).
Comparing the values of Q-PCR TCID50 to ocular and
IFA TCID50, one Q-PCR TCID50 equaled 1.41 ocular
and 1.03 IFA TCID50 based on 13 or 5 assessments
respectively. Q-PCR TCID50 did not give statistically
different values compared to ocular or IFA TCID50
(p = 0.41 or p = 0.29 respectively) (paired t-test) (Table 1).
Viral DNA copy numbers are often used as a rough es-
timate of the amount of viral particles a particular viral
batch contains. However, it is uncertain how well this
corresponds to infectivity. To assess this, TCID50 values
were compared with the viral DNA copy numbers for
the respective batch. The average ratios of viral DNA
load to Q-PCR TCID50 values in the virus batches were
similar for P17 and P19; 6.3*105 and 2.0*106 viral DNA
copies per TCID50 respectively. For P21 however,
the ratio was considerably higher, 1.3*108 viral
DNA copies per TCID50 (Table 1). Thus, measuring viral
DNA in batch’s supernatants is insufficient to correctly
assign the infectivity of a batch and therefore biological
assays should be performed to accurately determine viral
titers.The average intra-assay coefficient of variation (CV)
for Q-PCR TCID50 was 9%, determined by parallel du-
plicate extractions and Q-PCRs of three TCID50 culture
plates. For ocular TCID50 the intra-assay CV was 45%,
determined by a total of twelve TCID50 culture plates
read by two independent assessors. The intra-assay CV
was 14% for IFA TCID50 determined by two parallel
staining of cells from two runs. For the infectious units
approach the intra-assay CV was 43% determined by
four parallel staining of cells from one run. The average
inter-assay CV was 73% for Q-PCR TCID50 and 66% for
ocular TCID50, determined for three virus batches run
five, three and three times respectively. For IFA TCID50
the inter-assay CV was 25%, determined for one batch
run three times. For the infectious units approach the
inter-assay CV was 77%, determined by three separate
runs for one batch.
In summary, the Q-PCR TCID50 method described
here correlates well with expression of viral proteins and
thus has high specificity for infectious dose. It is more
robust than ocular TCID50, IFA TCID50 and the infec-
tious units approach, based on the intra-assay CV values.
The intra-assay CV is in this setting a measure of how
precise a certain read-out approach is and therefore is
the most accurate value for comparisons of the different
methods. To adapt the method, the cut point needs to be
determined for every viral strain tested and every cell line
used. The Q-PCR read-out approach is more laborious
than ocular inspection, but in our opinion considerably
less laborious than IFA TCID50 and the infectious units
approach. It is more expensive in terms of laboratory
resources than ocular inspection, IFA TCID50 and the in-
fectious units approach. However, our data stresses the
importance of performing biological assays to accurately
determine viral titers, which might warrant the cost and
labor. Furthermore, better standardization of viral titer
assessment methods used within the HHV-6 field might
increase the concordance between different studies.
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Additional file 1: Figure S1. Ocular inspection of HHV-6A (GS strain)
infected HSB-2 cells. Dilutions and positive (+) or negative (−) results in
Q-PCR TCID50 assessments are indicated. Undil: undiluted virus
supernatant, 1:5; five times dilution of the virus supernatant, 1:5^2; 25
times dilution of the virus supernatant dilution etcetera. The figure shows
one representative culture of sextuplicates for every dilution and of
twelve runs of TCID50 assessment by ocular inspection for enlarged cells
using phase contrast microscopy, 10 times enlargement.
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